Boule Diagnostic AB

Rapporter

Visar 2 grupper

  1. Kvartalsrapport Q1 2026

    ENSV
    →

    Financial Performance

    • Net sales amounted to SEK 101.6 million (112.9), a decrease of 10.0 percent.
    • Organic sales growth was 3.0 percent, while currency effects were -13.0 percent.
    • Adjusted operating profit amounted to SEK -1.4 million (17.0), corresponding to an adjusted operating margin of -1.3 percent (15.1).
    • Operating cash flow was SEK 17.7 million (-9.8),…
  2. Årsredovisning 2025

    SV
    →

    | Nyckeltal | 2025 | | :--- | :--- | | Nettoomsättning, MSEK | 489,7 | | Bruttomarginal, % | 43,7 | | Rörelseresultat (EBIT), MSEK | 20,8 | | Rörelsemarginal (EBIT), % | 4,3 | | Justerat rörelseresultat, MSEK | 46,2 | | Justerad rörelsemarginal, % | 9,4 | | Årets resultat, MSEK | -3,8 | | Resultat per aktie, SEK | -0,10 |